vimarsana.com

Latest Breaking News On - Benjaminl palleiko - Page 1 : vimarsana.com

HC Wainwright Trims KalVista Pharmaceuticals (NASDAQ:KALV) Target Price to $20 00

KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) had its price objective reduced by HC Wainwright from $24.00 to $20.00 in a research report report published on Friday morning, Benzinga reports. They currently have a buy rating on the specialty pharmaceutical company’s stock. Separately, Needham & Company LLC reiterated a buy rating and set a $35.00 price […]

KalVista Pharmaceuticals (KALV) Buy Rating Reiterated at Needham & Company LLC

KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report)‘s stock had its “buy” rating reaffirmed by Needham & Company LLC in a research report issued on Wednesday, Benzinga reports. They presently have a $35.00 price objective on the specialty pharmaceutical company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 191.67% from the stock’s […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.